1-(5-ethyl-1,2,4-oxadiazol-3-yl)-5-methyl-3-(methylamino)azepan-2-one;1-(furan-2-yl)-5-methyl-3-(methylamino)azepan-2-one;5-methyl-3-(methylamino)-1-(5-methyl-1,2,4-oxadiazol-3-yl)azepan-2-one;5-methyl-3-(methylamino)-1-(5-methyl-1,2,4-thiadiazol-3-yl)azepan-2-one;tetrakis(5-methyl-3-(methylamino)-1-(1,3-oxazol-2-yl)azepan-2-one);5-methyl-3-(methylamino)-1-pyrazin-2-ylazepan-2-one;5-methyl-3-(methylamino)-1-(1H-pyrrol-2-yl)azepan-2-one;5-methyl-3-(methylamino)-1-(1,3-thiazol-2-yl)azepan-2-one;5-methyl-3-(methylamino)-1-thiophen-2-ylazepan-2-one

C137H214N38O19S3 — CID 158379527

IUPAC1-(5-ethyl-1,2,4-oxadiazol-3-yl)-5-methyl-3-(methylamino)azepan-2-one;1-(furan-2-yl)-5-methyl-3-(methylamino)azepan-2-one;5-methyl-3-(methylamino)-1-(5-methyl-1,2,4-oxadiazol-3-yl)azepan-2-one;5-methyl-3-(methylamino)-1-(5-methyl-1,2,4-thiadiazol-3-yl)azepan-2-one;tetrakis(5-methyl-3-(methylamino)-1-(1,3-oxazol-2-yl)azepan-2-one);5-methyl-3-(methylamino)-1-pyrazin-2-ylazepan-2-one;5-methyl-3-(methylamino)-1-(1H-pyrrol-2-yl)azepan-2-one;5-methyl-3-(methylamino)-1-(1,3-thiazol-2-yl)azepan-2-one;5-methyl-3-(methylamino)-1-thiophen-2-ylazepan-2-one
SMILESCCc1nc(N2CCC(C)CC(NC)C2=O)no1.CNC1CC(C)CCN(c2ccc[nH]2)C1=O.CNC1CC(C)CCN(c2ccco2)C1=O.CNC1CC(C)CCN(c2cccs2)C1=O.CNC1CC(C)CCN(c2cnccn2)C1=O.CNC1CC(C)CCN(c2ncco2)C1=O.CNC1CC(C)CCN(c2ncco2)C1=O.CNC1CC(C)CCN(c2ncco2)C1=O.CNC1CC(C)CCN(c2ncco2)C1=O.CNC1CC(C)CCN(c2nccs2)C1=O.CNC1CC(C)CCN(c2noc(C)n2)C1=O.CNC1CC(C)CCN(c2nsc(C)n2)C1=O
InChIInChI=1S/C12H20N4O2.C12H18N4O.C12H19N3O.C12H18N2O2.C12H18N2OS.C11H18N4O2.C11H18N4OS.4C11H17N3O2.C11H17N3OS/c1-4-10-14-12(15-18-10)16-6-5-8(2)7-9(13-3)11(16)17;1-9-3-6-16(11-8-14-4-5-15-11)12(17)10(7-9)13-2;1-9-5-7-15(11-4-3-6-14-11)12(16)10(8-9)13-2;2*1-9-5-6-14(11-4-3-7-16-11)12(15)10(8-9)13-2;2*1-7-4-5-15(10(16)9(6-7)12-3)11-13-8(2)17-14-11;5*1-8-3-5-14(11-13-4-6-16-11)10(15)9(7-8)12-2/h8-9,13H,4-7H2,1-3H3;4-5,8-10,13H,3,6-7H2,1-2H3;3-4,6,9-10,13-14H,5,7-8H2,1-2H3;2*3-4,7,9-10,13H,5-6,8H2,1-2H3;2*7,9,12H,4-6H2,1-3H3;5*4,6,8-9,12H,3,5,7H2,1-2H3
InChIKeyGVPREAMIYSVJBP-UHFFFAOYSA-N
MW2793.67 g/mol
LogP14.43
Rot. Bonds25

About 1-(5-ethyl-1,2,4-oxadiazol-3-yl)-5-methyl-3-(methylamino)azepan-2-one;1-(furan-2-yl)-5-methyl-3-(methylamino)azepan-2-one;5-methyl-3-(methylamino)-1-(5-methyl-1,2,4-oxadiazol-3-yl)azepan-2-one;5-methyl-3-(methylamino)-1-(5-methyl-1,2,4-thiadiazol-3-yl)azepan-2-one;tetrakis(5-methyl-3-(methylamino)-1-(1,3-oxazol-2-yl)azepan-2-one);5-methyl-3-(methylamino)-1-pyrazin-2-ylazepan-2-one;5-methyl-3-(methylamino)-1-(1H-pyrrol-2-yl)azepan-2-one;5-methyl-3-(methylamino)-1-(1,3-thiazol-2-yl)azepan-2-one;5-methyl-3-(methylamino)-1-thiophen-2-ylazepan-2-one

1-(5-ethyl-1,2,4-oxadiazol-3-yl)-5-methyl-3-(methylamino)azepan-2-one;1-(furan-2-yl)-5-methyl-3-(methylamino)azepan-2-one;5-methyl-3-(methylamino)-1-(5-methyl-1,2,4-oxadiazol-3-yl)azepan-2-one;5-methyl-3-(methylamino)-1-(5-methyl-1,2,4-thiadiazol-3-yl)azepan-2-one;tetrakis(5-methyl-3-(methylamino)-1-(1,3-oxazol-2-yl)azepan-2-one);5-methyl-3-(methylamino)-1-pyrazin-2-ylazepan-2-one;5-methyl-3-(methylamino)-1-(1H-pyrrol-2-yl)azepan-2-one;5-methyl-3-(methylamino)-1-(1,3-thiazol-2-yl)azepan-2-one;5-methyl-3-(methylamino)-1-thiophen-2-ylazepan-2-one (PubChem CID 158379527) has the molecular formula C137H214N38O19S3 and a molecular weight of 2793.67 g/mol. Its IUPAC name is 1-(5-ethyl-1,2,4-oxadiazol-3-yl)-5-methyl-3-(methylamino)azepan-2-one;1-(furan-2-yl)-5-methyl-3-(methylamino)azepan-2-one;5-methyl-3-(methylamino)-1-(5-methyl-1,2,4-oxadiazol-3-yl)azepan-2-one;5-methyl-3-(methylamino)-1-(5-methyl-1,2,4-thiadiazol-3-yl)azepan-2-one;tetrakis(5-methyl-3-(methylamino)-1-(1,3-oxazol-2-yl)azepan-2-one);5-methyl-3-(methylamino)-1-pyrazin-2-ylazepan-2-one;5-methyl-3-(methylamino)-1-(1H-pyrrol-2-yl)azepan-2-one;5-methyl-3-(methylamino)-1-(1,3-thiazol-2-yl)azepan-2-one;5-methyl-3-(methylamino)-1-thiophen-2-ylazepan-2-one.

Molecular Properties

Compound Name1-(5-ethyl-1,2,4-oxadiazol-3-yl)-5-methyl-3-(methylamino)azepan-2-one;1-(furan-2-yl)-5-methyl-3-(methylamino)azepan-2-one;5-methyl-3-(methylamino)-1-(5-methyl-1,2,4-oxadiazol-3-yl)azepan-2-one;5-methyl-3-(methylamino)-1-(5-methyl-1,2,4-thiadiazol-3-yl)azepan-2-one;tetrakis(5-methyl-3-(methylamino)-1-(1,3-oxazol-2-yl)azepan-2-one);5-methyl-3-(methylamino)-1-pyrazin-2-ylazepan-2-one;5-methyl-3-(methylamino)-1-(1H-pyrrol-2-yl)azepan-2-one;5-methyl-3-(methylamino)-1-(1,3-thiazol-2-yl)azepan-2-one;5-methyl-3-(methylamino)-1-thiophen-2-ylazepan-2-one
PubChem CID158379527
Molecular FormulaC137H214N38O19S3
Molecular Weight2793.67 g/mol
Exact Mass2791.61
IUPAC Name1-(5-ethyl-1,2,4-oxadiazol-3-yl)-5-methyl-3-(methylamino)azepan-2-one;1-(furan-2-yl)-5-methyl-3-(methylamino)azepan-2-one;5-methyl-3-(methylamino)-1-(5-methyl-1,2,4-oxadiazol-3-yl)azepan-2-one;5-methyl-3-(methylamino)-1-(5-methyl-1,2,4-thiadiazol-3-yl)azepan-2-one;tetrakis(5-methyl-3-(methylamino)-1-(1,3-oxazol-2-yl)azepan-2-one);5-methyl-3-(methylamino)-1-pyrazin-2-ylazepan-2-one;5-methyl-3-(methylamino)-1-(1H-pyrrol-2-yl)azepan-2-one;5-methyl-3-(methylamino)-1-(1,3-thiazol-2-yl)azepan-2-one;5-methyl-3-(methylamino)-1-thiophen-2-ylazepan-2-one
SMILESCCc1nc(N2CCC(C)CC(NC)C2=O)no1.CNC1CC(C)CCN(c2ccc[nH]2)C1=O.CNC1CC(C)CCN(c2ccco2)C1=O.CNC1CC(C)CCN(c2cccs2)C1=O.CNC1CC(C)CCN(c2cnccn2)C1=O.CNC1CC(C)CCN(c2ncco2)C1=O.CNC1CC(C)CCN(c2ncco2)C1=O.CNC1CC(C)CCN(c2ncco2)C1=O.CNC1CC(C)CCN(c2ncco2)C1=O.CNC1CC(C)CCN(c2nccs2)C1=O.CNC1CC(C)CCN(c2noc(C)n2)C1=O.CNC1CC(C)CCN(c2nsc(C)n2)C1=O
InChIInChI=1S/C12H20N4O2.C12H18N4O.C12H19N3O.C12H18N2O2.C12H18N2OS.C11H18N4O2.C11H18N4OS.4C11H17N3O2.C11H17N3OS/c1-4-10-14-12(15-18-10)16-6-5-8(2)7-9(13-3)11(16)17;1-9-3-6-16(11-8-14-4-5-15-11)12(17)10(7-9)13-2;1-9-5-7-15(11-4-3-6-14-11)12(16)10(8-9)13-2;2*1-9-5-6-14(11-4-3-7-16-11)12(15)10(8-9)13-2;2*1-7-4-5-15(10(16)9(6-7)12-3)11-13-8(2)17-14-11;5*1-8-3-5-14(11-13-4-6-16-11)10(15)9(7-8)12-2/h8-9,13H,4-7H2,1-3H3;4-5,8-10,13H,3,6-7H2,1-2H3;3-4,6,9-10,13-14H,5,7-8H2,1-2H3;2*3-4,7,9-10,13H,5-6,8H2,1-2H3;2*7,9,12H,4-6H2,1-3H3;5*4,6,8-9,12H,3,5,7H2,1-2H3
InChIKeyGVPREAMIYSVJBP-UHFFFAOYSA-N
XLogP14.43
TPSA663.42 Ų
H-Bond Donors13
H-Bond Acceptors47
Rotatable Bonds25
Heavy Atoms197
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002793.67
LogP ≤ 514.43
H-Bond Donors ≤ 513
H-Bond Acceptors ≤ 1047

Analyze 1-(5-ethyl-1,2,4-oxadiazol-3-yl)-5-methyl-3-(methylamino)azepan-2-one;1-(furan-2-yl)-5-methyl-3-(methylamino)azepan-2-one;5-methyl-3-(methylamino)-1-(5-methyl-1,2,4-oxadiazol-3-yl)azepan-2-one;5-methyl-3-(methylamino)-1-(5-methyl-1,2,4-thiadiazol-3-yl)azepan-2-one;tetrakis(5-methyl-3-(methylamino)-1-(1,3-oxazol-2-yl)azepan-2-one);5-methyl-3-(methylamino)-1-pyrazin-2-ylazepan-2-one;5-methyl-3-(methylamino)-1-(1H-pyrrol-2-yl)azepan-2-one;5-methyl-3-(methylamino)-1-(1,3-thiazol-2-yl)azepan-2-one;5-methyl-3-(methylamino)-1-thiophen-2-ylazepan-2-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 1-(5-ethyl-1,2,4-oxadiazol-3-yl)-5-methyl-3-(methylamino)azepan-2-one;1-(furan-2-yl)-5-methyl-3-(methylamino)azepan-2-one;5-methyl-3-(methylamino)-1-(5-methyl-1,2,4-oxadiazol-3-yl)azepan-2-one;5-methyl-3-(methylamino)-1-(5-methyl-1,2,4-thiadiazol-3-yl)azepan-2-one;tetrakis(5-methyl-3-(methylamino)-1-(1,3-oxazol-2-yl)azepan-2-one);5-methyl-3-(methylamino)-1-pyrazin-2-ylazepan-2-one;5-methyl-3-(methylamino)-1-(1H-pyrrol-2-yl)azepan-2-one;5-methyl-3-(methylamino)-1-(1,3-thiazol-2-yl)azepan-2-one;5-methyl-3-(methylamino)-1-thiophen-2-ylazepan-2-one?
The IUPAC name of 1-(5-ethyl-1,2,4-oxadiazol-3-yl)-5-methyl-3-(methylamino)azepan-2-one;1-(furan-2-yl)-5-methyl-3-(methylamino)azepan-2-one;5-methyl-3-(methylamino)-1-(5-methyl-1,2,4-oxadiazol-3-yl)azepan-2-one;5-methyl-3-(methylamino)-1-(5-methyl-1,2,4-thiadiazol-3-yl)azepan-2-one;tetrakis(5-methyl-3-(methylamino)-1-(1,3-oxazol-2-yl)azepan-2-one);5-methyl-3-(methylamino)-1-pyrazin-2-ylazepan-2-one;5-methyl-3-(methylamino)-1-(1H-pyrrol-2-yl)azepan-2-one;5-methyl-3-(methylamino)-1-(1,3-thiazol-2-yl)azepan-2-one;5-methyl-3-(methylamino)-1-thiophen-2-ylazepan-2-one (CID 158379527) is 1-(5-ethyl-1,2,4-oxadiazol-3-yl)-5-methyl-3-(methylamino)azepan-2-one;1-(furan-2-yl)-5-methyl-3-(methylamino)azepan-2-one;5-methyl-3-(methylamino)-1-(5-methyl-1,2,4-oxadiazol-3-yl)azepan-2-one;5-methyl-3-(methylamino)-1-(5-methyl-1,2,4-thiadiazol-3-yl)azepan-2-one;tetrakis(5-methyl-3-(methylamino)-1-(1,3-oxazol-2-yl)azepan-2-one);5-methyl-3-(methylamino)-1-pyrazin-2-ylazepan-2-one;5-methyl-3-(methylamino)-1-(1H-pyrrol-2-yl)azepan-2-one;5-methyl-3-(methylamino)-1-(1,3-thiazol-2-yl)azepan-2-one;5-methyl-3-(methylamino)-1-thiophen-2-ylazepan-2-one.
What is the SMILES notation for 1-(5-ethyl-1,2,4-oxadiazol-3-yl)-5-methyl-3-(methylamino)azepan-2-one;1-(furan-2-yl)-5-methyl-3-(methylamino)azepan-2-one;5-methyl-3-(methylamino)-1-(5-methyl-1,2,4-oxadiazol-3-yl)azepan-2-one;5-methyl-3-(methylamino)-1-(5-methyl-1,2,4-thiadiazol-3-yl)azepan-2-one;tetrakis(5-methyl-3-(methylamino)-1-(1,3-oxazol-2-yl)azepan-2-one);5-methyl-3-(methylamino)-1-pyrazin-2-ylazepan-2-one;5-methyl-3-(methylamino)-1-(1H-pyrrol-2-yl)azepan-2-one;5-methyl-3-(methylamino)-1-(1,3-thiazol-2-yl)azepan-2-one;5-methyl-3-(methylamino)-1-thiophen-2-ylazepan-2-one?
The canonical SMILES for 1-(5-ethyl-1,2,4-oxadiazol-3-yl)-5-methyl-3-(methylamino)azepan-2-one;1-(furan-2-yl)-5-methyl-3-(methylamino)azepan-2-one;5-methyl-3-(methylamino)-1-(5-methyl-1,2,4-oxadiazol-3-yl)azepan-2-one;5-methyl-3-(methylamino)-1-(5-methyl-1,2,4-thiadiazol-3-yl)azepan-2-one;tetrakis(5-methyl-3-(methylamino)-1-(1,3-oxazol-2-yl)azepan-2-one);5-methyl-3-(methylamino)-1-pyrazin-2-ylazepan-2-one;5-methyl-3-(methylamino)-1-(1H-pyrrol-2-yl)azepan-2-one;5-methyl-3-(methylamino)-1-(1,3-thiazol-2-yl)azepan-2-one;5-methyl-3-(methylamino)-1-thiophen-2-ylazepan-2-one is CCc1nc(N2CCC(C)CC(NC)C2=O)no1.CNC1CC(C)CCN(c2ccc[nH]2)C1=O.CNC1CC(C)CCN(c2ccco2)C1=O.CNC1CC(C)CCN(c2cccs2)C1=O.CNC1CC(C)CCN(c2cnccn2)C1=O.CNC1CC(C)CCN(c2ncco2)C1=O.CNC1CC(C)CCN(c2ncco2)C1=O.CNC1CC(C)CCN(c2ncco2)C1=O.CNC1CC(C)CCN(c2ncco2)C1=O.CNC1CC(C)CCN(c2nccs2)C1=O.CNC1CC(C)CCN(c2noc(C)n2)C1=O.CNC1CC(C)CCN(c2nsc(C)n2)C1=O.
What is the InChIKey of 1-(5-ethyl-1,2,4-oxadiazol-3-yl)-5-methyl-3-(methylamino)azepan-2-one;1-(furan-2-yl)-5-methyl-3-(methylamino)azepan-2-one;5-methyl-3-(methylamino)-1-(5-methyl-1,2,4-oxadiazol-3-yl)azepan-2-one;5-methyl-3-(methylamino)-1-(5-methyl-1,2,4-thiadiazol-3-yl)azepan-2-one;tetrakis(5-methyl-3-(methylamino)-1-(1,3-oxazol-2-yl)azepan-2-one);5-methyl-3-(methylamino)-1-pyrazin-2-ylazepan-2-one;5-methyl-3-(methylamino)-1-(1H-pyrrol-2-yl)azepan-2-one;5-methyl-3-(methylamino)-1-(1,3-thiazol-2-yl)azepan-2-one;5-methyl-3-(methylamino)-1-thiophen-2-ylazepan-2-one?
The InChIKey is GVPREAMIYSVJBP-UHFFFAOYSA-N. The full InChI is InChI=1S/C12H20N4O2.C12H18N4O.C12H19N3O.C12H18N2O2.C12H18N2OS.C11H18N4O2.C11H18N4OS.4C11H17N3O2.C11H17N3OS/c1-4-10-14-12(15-18-10)16-6-5-8(2)7-9(13-3)11(16)17;1-9-3-6-16(11-8-14-4-5-15-11)12(17)10(7-9)13-2;1-9-5-7-15(11-4-3-6-14-11)12(16)10(8-9)13-2;2*1-9-5-6-14(11-4-3-7-16-11)12(15)10(8-9)13-2;2*1-7-4-5-15(10(16)9(6-7)12-3)11-13-8(2)17-14-11;5*1-8-3-5-14(11-13-4-6-16-11)10(15)9(7-8)12-2/h8-9,13H,4-7H2,1-3H3;4-5,8-10,13H,3,6-7H2,1-2H3;3-4,6,9-10,13-14H,5,7-8H2,1-2H3;2*3-4,7,9-10,13H,5-6,8H2,1-2H3;2*7,9,12H,4-6H2,1-3H3;5*4,6,8-9,12H,3,5,7H2,1-2H3.
What are the key properties of 1-(5-ethyl-1,2,4-oxadiazol-3-yl)-5-methyl-3-(methylamino)azepan-2-one;1-(furan-2-yl)-5-methyl-3-(methylamino)azepan-2-one;5-methyl-3-(methylamino)-1-(5-methyl-1,2,4-oxadiazol-3-yl)azepan-2-one;5-methyl-3-(methylamino)-1-(5-methyl-1,2,4-thiadiazol-3-yl)azepan-2-one;tetrakis(5-methyl-3-(methylamino)-1-(1,3-oxazol-2-yl)azepan-2-one);5-methyl-3-(methylamino)-1-pyrazin-2-ylazepan-2-one;5-methyl-3-(methylamino)-1-(1H-pyrrol-2-yl)azepan-2-one;5-methyl-3-(methylamino)-1-(1,3-thiazol-2-yl)azepan-2-one;5-methyl-3-(methylamino)-1-thiophen-2-ylazepan-2-one?
1-(5-ethyl-1,2,4-oxadiazol-3-yl)-5-methyl-3-(methylamino)azepan-2-one;1-(furan-2-yl)-5-methyl-3-(methylamino)azepan-2-one;5-methyl-3-(methylamino)-1-(5-methyl-1,2,4-oxadiazol-3-yl)azepan-2-one;5-methyl-3-(methylamino)-1-(5-methyl-1,2,4-thiadiazol-3-yl)azepan-2-one;tetrakis(5-methyl-3-(methylamino)-1-(1,3-oxazol-2-yl)azepan-2-one);5-methyl-3-(methylamino)-1-pyrazin-2-ylazepan-2-one;5-methyl-3-(methylamino)-1-(1H-pyrrol-2-yl)azepan-2-one;5-methyl-3-(methylamino)-1-(1,3-thiazol-2-yl)azepan-2-one;5-methyl-3-(methylamino)-1-thiophen-2-ylazepan-2-one has a molecular weight of 2793.67 g/mol, XLogP of 14.43, 25 rotatable bonds, 13 hydrogen bond donors, and 47 hydrogen bond acceptors.
Where does this data come from?
All data for 1-(5-ethyl-1,2,4-oxadiazol-3-yl)-5-methyl-3-(methylamino)azepan-2-one;1-(furan-2-yl)-5-methyl-3-(methylamino)azepan-2-one;5-methyl-3-(methylamino)-1-(5-methyl-1,2,4-oxadiazol-3-yl)azepan-2-one;5-methyl-3-(methylamino)-1-(5-methyl-1,2,4-thiadiazol-3-yl)azepan-2-one;tetrakis(5-methyl-3-(methylamino)-1-(1,3-oxazol-2-yl)azepan-2-one);5-methyl-3-(methylamino)-1-pyrazin-2-ylazepan-2-one;5-methyl-3-(methylamino)-1-(1H-pyrrol-2-yl)azepan-2-one;5-methyl-3-(methylamino)-1-(1,3-thiazol-2-yl)azepan-2-one;5-methyl-3-(methylamino)-1-thiophen-2-ylazepan-2-one is sourced from PubChem (CID 158379527), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).